Company: LIMN
Filing Date: 2025-06-02
Form Type: 8-K/A
Source: 0001104659-25-055078
Chunk: 16

Company: Liminatus Pharma, Inc.
Filing Date: 2025-06-02
Form: 8-K/A
Chunk 16
---
 party, of $0.7 million (the “Valetudo Loan”) issued in December 2022 and due in June 2023,
and which bears no interest, our loan with Ewon Comfortech Co., Ltd. (“Ewon”), our shareholder and related party, of
$2.0 million (the “Ewon Loan”) issued in December 2022 and due in December 2023, and related interest of 2% per
annum, our loans with Valetudo of $0.5 million issued in June 2023 and due in December 2023 that does not bear interest (the
“Valetudo June 2023 Loans”), our additional loan with Valetudo of $0.3 million issued in July 2023 and due in January 2024,
and related interest of 6% per annum (the “Valetudo July 2023 Loan”), our loans with Valetudo issued in August 2023
totaling $0.4 million, due in January and February 2024, and related interest of 6% per annum (the “Valetudo August 2023
Loans”), our additional loan with Ewon of $0.2 million issued in September 2023 and due in September 2024 and related
part interest of 2% per annum (the “Ewon September 2023 Loan”), our additional loan with Valetudo of $0.2 million issued
in November 2023, due in January 2024 and related interest of 6% per annum (the “Valetudo November 2023 Loan”),
our other loan with Ewon of $1.0 million issued in December 2023, due in December 2024 that bears no interest (the “Ewon
December 2023 Loan”), our loans with Valetudo issued in January 2024 totaling $0.8 million, due in February 2024,
and related interest of 6% per annum (the “Valetudo January 2024 Loans”), our loan with Prophase Sciences LLC (“Prophase”)
of $0.2 million issued February 2024 that bears 6% interest per annum and due June 1, 2024 (the “Prophase February 2024
Loan”), our loan with Prophase issued in March 2024 of $0.3 million that bears interest of 6% per annum and due June 1,
2024 (